116 drug patents listed in Korea’s green list in May

The Ministry of Food and Drug Safety (MFDS) said Thursday that 116 medicinal products (most of foreign drugs except Handok Pharm’s Soliris and Aggrastat and Hyundai Pharm’s Zindaclin) were newly included into green list in May, which can be compared to the "Orange Book" in the U.S.

The MFDS said that a total of 1,068 drug patents were registered into the list for a January-May period. Detail...